Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care . 2001;24(11):1936-1940.
2.
Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJImpact of recent increase in incidence on future diabetes burden: U.S., 2005-2050 . Diabetes Care. 2006;29(9):2114-2116.
3.
Hogan P., Dall T., Nikolov P.Economic costs of diabetes in the U.S. in 2002. Diabetes Care . 2003;26(3):917-931.
4.
Signorello LB , Schlundt DG, Cohen SS, et al. Comparing diabetes prevalence between African Americans and Whites of similar socio-economic status. Am J Public Health. 2007;97(12):2260-2267.
5.
Umpierrez GE , Gonzalez A., Umpierrez D., Pimentel D.Diabetes mellitus in the Hispanic/Latino population: an increasing health care challenge in the United States. Am J Med Sci. 2007;334(4):274-282.
6.
Boltri JM, Okosun IS, Davis-Smith M., Vogel RLHemoglobin A1c levels in diagnosed and undiagnosed black, Hispanic, and white persons with diabetes: results from NHANES 1999-2000. Ethn Dis. 2005;15(4):562-567.
7.
Saydah S., Cowie C., Eberhardt MS, De Rekeneire N., Narayan KMRace and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. Ethn Dis. 2007 ; 17(3):529-535.
8.
Gary TL, Narayan KM, Gregg EW, Beckles GL, Saaddine JBRacial/ethnic differences in the healthcare experience (coverage, utilization, and satisfaction) of US adults with diabetes. Ethn Dis. 2003;13(1):47-54.
9.
Goldstein DE , Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabetes Care. 2004;27:1761-1773.
10.
Rohlfing CL , Wiedmeyer HM, Little RR, et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25:275-278.
